Avenir Wellness Solutions, Inc.

AVRW

US23127P1049

Software

Market Closed - OTC Markets Other stock markets 09:54:34 2024-06-27 EDT			5-day change	1st Jan Change
0.05 ^USD	+2.04%		+20.19%	-32.80%

05-30	Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-17	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

CURE Pharmaceutical Names Steven Ruhl as Vice President of Manufacturing

March 14, 2018 at 09:00 am

CURE Pharmaceutical named Steven Ruhl as Vice President of Manufacturing. Bringing more than 35 years of experience, Ruhl will oversee all process development and manufacturing operations.

Latest news about Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05-17	CI
Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement	01-12	CI
Avenir Wellness Solutions, Inc. announced that it expects to receive $0.25 million in funding	01-03	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Avenir Wellness Solutions, Inc. Provides Sales Guidance for the Second Half of 2023	23-08-15	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Avenir Wellness Solutions, Inc. will Change its Ticker to AVRW from CURR	23-08-09	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-28	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-07-28	CI
Avenir Wellness Solutions to Launch Wall Street-Focused Informational Series with Producer New to the Street	23-01-19	CI
CURE Pharmaceutical Holding Corp. has Changed its Name to Avenir Wellness Solutions, Inc	23-01-17	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-02	CI
CURE Pharmaceutical Holding Corp. Announces Board and Committee Appointments	22-08-16	CI
CURE Pharmaceutical Holding Corp. Appoints Gerald Bagg to Its Board of Directors	22-08-02	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-01	CI
CURE Pharmaceutical Holding Corp. Auditor Raises 'Going Concern' Doubt	22-03-31	CI
CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico	22-03-03	CI
CURE Pharmaceutical Holding Corp. Announces Resignation of Directors	21-12-03	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
CURE Pharmaceutical Holding Corp. Announces Revenue Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Cure Pharmaceutical Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI

Chart Avenir Wellness Solutions, Inc.

Duration

Period

More charts

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Companyâs wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.

Sector

Software

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Software

	1st Jan change	Capi.
AVENIR WELLNESS SOLUTIONS, INC.	-32.80%	3.9M
MICROSOFT CORPORATION	+20.43%	3,366B
SYNOPSYS INC.	+15.55%	91.16B
CADENCE DESIGN SYSTEMS, INC.	+13.05%	84.42B
PALANTIR TECHNOLOGIES INC.	+46.88%	56.16B
DASSAULT SYSTÈMES SE	-20.76%	49.25B
THE TRADE DESK, INC.	+36.49%	48.04B
ATLASSIAN CORPORATION	-27.27%	45.03B
SEA LIMITED	+83.98%	42.79B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-2.47%	27.47B